Akèy › Kansè kolorektal › New Jersey › Edison
Etid klinik pou Kansè kolorektal nan Edison, NJ
23 etid pou Kansè kolorektal ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Astera Cancer Care /ID# 279532, East Brunswick · 6 mi lwen
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- START New Jersey, East Brunswick · 6 mi lwen
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #88, East Brunswick · 6 mi lwen
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, New Brunswick · 3 mi lwen
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Ap rekriteFaz 2
- START New Jersey, East Brunswick · 6 mi lwen
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Ap rekriteFaz 3
- Astera Cancer Care, East Brunswick · 6 mi lwen
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Ap rekriteFaz 3
- Rutgers Cancer Institute, New Brunswick · 3 mi lwen
- Astera Cancer Care, East Brunswick · 6 mi lwen
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Ap rekriteFaz 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Ap rekriteFaz 2
- Research Site, East Brunswick · 6 mi lwen
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Ap rekriteFaz 3
- Astera Cancer Care, Edison
- Astera Cancer Care, Somerset · 4 mi lwen
- Astera Cancer Care, East Brunswick · 6 mi lwen
- ak 1 plis
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Clinical Study Site, New Brunswick · 3 mi lwen
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Ap rekriteFaz 2
- Rutgers Cancer Institute, New Brunswick · 3 mi lwen
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Ap rekriteFaz 3
- MSK Basking Ridge, Basking Ridge · 15 mi lwen
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START Astera, LLC, East Brunswick · 6 mi lwen
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Ap rekriteFaz 1/2
- START, Astera, East Brunswick · 6 mi lwen
Collection of Information to Better Understand Young Onset Colorectal Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Ap rekriteFaz 4
- Jack and Sheryl Morris Cancer Center, New Brunswick · 3 mi lwen
- RWJBarnabas Health - Robert Wood Johnson University Hospita, New Brunswick · 3 mi lwen
- RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville · 11 mi lwen
Etid Kansè kolorektal nan lòt vil
- Houston, TX102 etid
- New York City, NY77 etid
- Nashville, TN69 etid
- Boston, MA63 etid
- Los Angeles, CA59 etid
- Arlington, VA52 etid
- St. Louis, MO50 etid
- San Antonio, TX46 etid
- Philadelphia, PA44 etid
- Grand Rapids, MI40 etid
- Baldwin Park, CA38 etid
- Seattle, WA34 etid
Lòt etid nan Edison
- Kansè nan tete68 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat29 etid
- Kansè poumon23 etid
- Myelom Miltip22 etid
- Kansè vejik21 etid
- Kansè Metastatik20 etid
- Kansè ovè20 etid
- Leksemi mieloïd egi20 etid
- Kansè Endomèt19 etid
- Kasinom Selil Transizyonèl (Urotelyal)18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.